Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Arvee Laboratories (India) 14-Day RSI Related Terms
NSE:ARVEE vs LIN, SHW, ECL: 14-Day RSI Comparison
For the Specialty Chemicals subindustry, Arvee Laboratories (India)'s 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvee Laboratories (India) 14-Day RSI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Arvee Laboratories (India)'s 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Arvee Laboratories (India)'s 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arvee Laboratories (India) (NSE:ARVEE) has a 14-Day RSI of 65.18 as of Sep. 22, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Arvee Laboratories (India) and its competitors. According to the industry distribution chart, Arvee Laboratories (India) ranks #956 out of 1661 companies in the Chemicals industry, placing it in the top 57.6%.
Is Arvee Laboratories (India)'s 14-Day RSI too high?
Arvee Laboratories (India)'s current 14-Day RSI is 65.18. The Chemicals industry median 14-Day RSI is 48.54. Arvee Laboratories (India)'s value of 65.18 is 34.3% above this industry median. Based on the distribution chart, Arvee Laboratories (India) ranks #956 out of 1661 companies in the Chemicals industry, which is below the industry midpoint. Overall, Arvee Laboratories (India) has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvee Laboratories (India)'s 14-Day RSI compare to LIN and SHW?
According to the Chemicals industry distribution chart, Arvee Laboratories (India) ranks #956 out of 1661 companies for 14-Day RSI. This places Arvee Laboratories (India) in the lower half of its industry. The industry median 14-Day RSI is 48.54. Arvee Laboratories (India)'s value of 65.18 is 34.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Chemicals company?
The median 14-Day RSI among Chemicals companies is 48.54, based on 1,661 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arvee Laboratories (India)'s current 14-Day RSI of 65.18 is 34.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Arvee Laboratories (India) and its competitors. For the Chemicals industry, the median 14-Day RSI is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arvee Laboratories (India)'s current 14-Day RSI is 65.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvee Laboratories (India) stock overvalued right now?
Based on GuruFocus' analysis, Arvee Laboratories (India) (NSE:ARVEE) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹187.98, compared to a current price of ₹208.87 — trading 11.1% above its estimated fair value. The current 14-Day RSI is 65.18 and 34.3% above the Chemicals industry median of 48.54. Arvee Laboratories (India)'s overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Arvee Laboratories (India) (NSE:ARVEE), the current 14-Day RSI is 65.18 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arvee Laboratories (India) (NSE:ARVEE) Overvalued in 2026?
Based on GuruFocus' analysis, Arvee Laboratories (India) stock appears to be overvalued.
The current stock price of ₹208.87 is trading 11.1% above its estimated GF Value™ of ₹187.98.
GuruFocus considers Arvee Laboratories (India) to be Modestly Overvalued.
Key valuation signals for NSE:ARVEE:
14-Day RSI: 65.18
GF Value™: ₹187.98 vs. price of ₹208.87 (11.1% above fair value)
Industry Position: 34.3% above the Chemicals median (#956 of 1661)
No single metric tells the full story. See the NSE:ARVEE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvee Laboratories (India) Ltd is a specialty chemical company. Its products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, the company principally operates in India.
73GF Score
Get the complete analysis for NSE:ARVEE
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ARVEE has been successfully added to your 
